Skip to main content
Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.10
-0.46 (-4.81%)
At close: Mar 5, 2026, 4:00 PM EST
9.11
+0.01 (0.11%)
Pre-market: Mar 6, 2026, 5:38 AM EST

Vir Biotechnology Revenue by Segment
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Collaboration
63.13M 9.78M 8.75M 9.30M 8.37M 6.85M 12.34M -1.49M - - - - - - - - -
Collaboration Growth
654.60% 42.75% -29.14% - -81.86% -88.35% -96.60% - - - - - - - - - -
Contract
- - 5.65M 5.01M 55.34M 55.18M 54.08M 54.25M 2.15M 1.65M
Contract Growth
- - -89.56% -90.77% 2,478.84% 3,252.19% 30.75% 3.22% -95.93% -96.88%
Grant
2.04M 2.82M 4.61M 6.56M 10.52M 16.63M 21.27M 35.66M
Grant Growth
-80.65% -83.03% -78.34% -81.60% -77.45% -75.21% -66.46% -27.17%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.